Skip to main navigation
Skip to search
Skip to main content
Tel Aviv University Home
Update Request & User Guide (TAU staff only)
Link opens in a new tab
Search content at Tel Aviv University
Home
Experts
Research units
Research output
Datasets
Prizes
Activities
Press/Media
Safety of benzodiazepines in newborns
Eugene Ng
*
,
Gil Klinger
, Vibhuti Shah
, Anna Taddio
, Annette Pérez
, Louise Gagnon
*
Corresponding author for this work
University of Toronto
Research output
:
Contribution to journal
›
Article
›
peer-review
53
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Safety of benzodiazepines in newborns'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Benzodiazepines
100%
Adverse Effects
83%
Seizure
33%
Anticonvulsant
33%
Full-term Infants
33%
Hypotension
33%
Respiratory Depression
33%
Inotropes
33%
Benzodiazepine Dependence
33%
Birth Weight
16%
Morphine
16%
Analgesic
16%
Illness
16%
Adverse Events
16%
Serious Adverse Effects
16%
Drug Administration
16%
Risk-benefit Ratio
16%
Median Range
16%
Neonatal Intensive Care Unit
16%
Preterm Infants
16%
Vulnerable Populations
16%
Gestational Age
16%
Retrospective Chart Review
16%
Midazolam
16%
Sedative
16%
Sedation
16%
Postnatal Age
16%
Lorazepam
16%
Adverse Drug Reaction
16%
Multiple Drugs
16%
Probability Scale
16%
Ventilatory Support
16%
Concomitant Use
16%
Underlying Medical Conditions
16%
Reaction Probability
16%
Concomitant Drug Use
16%
Anecdotal Evidence
16%
Medicine and Dentistry
Adverse Event
100%
Neonatal Infant
100%
Benzodiazepine Derivative
100%
Benzodiazepine
42%
Epileptic Seizure
28%
Hypotension
28%
Anticonvulsant
28%
Inotropic Agent
28%
Respiration Depression
28%
Drug Use
14%
Neonatal Intensive Care Unit
14%
Birth Weight
14%
Vulnerable Population
14%
Sedative Agent
14%
Midazolam
14%
Adverse Drug Reaction
14%
Drug Administration
14%
Concomitant Drug
14%
Lorazepam
14%
Gestational Age
14%
Diseases
14%
Morphine
14%